ASCO GU

ASCO GU Conference Content

featured article image

PD1/L1 Inhibitor Therapy for Muscle-Invasive Bladder Cancer: Adjuvant or Neoadjuvant + Adjuvant?

Guru P Sonpavde, MD

Feb 21, 2025